These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18220670)

  • 1. Sympathetic mechanisms of hypoglycemic counterregulation.
    Hoffman RP
    Curr Diabetes Rev; 2007 Aug; 3(3):185-93. PubMed ID: 18220670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
    Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
    J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man.
    Garber AJ; Cryer PE; Santiago JV; Haymond MW; Pagliara AS; Kipnis DM
    J Clin Invest; 1976 Jul; 58(1):7-15. PubMed ID: 6491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
    Cryer PE; Gerich JE
    N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine responses and their interactions with other glucoregulatory hormones.
    Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemia in diabetes.
    Cryer PE; Davis SN; Shamoon H
    Diabetes Care; 2003 Jun; 26(6):1902-12. PubMed ID: 12766131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus.
    Gerich JE
    Diabetes; 1988 Dec; 37(12):1608-17. PubMed ID: 3056759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic mechanisms in glucose counterregulation in normal and diabetic man.
    Cryer PE
    Cardiovasc Res; 1982 Jul; 16(7):370-6. PubMed ID: 6751534
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoglycemia in diabetes: pathophysiological mechanisms and diurnal variation.
    Cryer PE
    Prog Brain Res; 2006; 153():361-5. PubMed ID: 16876586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrine.
    Cryer PE; Gerich JE
    Diabetes Care; 1983; 6(1):95-9. PubMed ID: 6341018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and local adrenergic regulation of muscle glucose utilization during hypoglycemia in healthy subjects.
    Hoffman RP; Sinkey CA; Dopp JM; Phillips BG
    Diabetes; 2002 Mar; 51(3):734-42. PubMed ID: 11872674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
    De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
    Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes.
    Cryer PE
    Diabetes; 2005 Dec; 54(12):3592-601. PubMed ID: 16306382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia.
    Schmid SM; Hallschmid M; Jauch-Chara K; Bandorf N; Born J; Schultes B
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3044-51. PubMed ID: 17519315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of stress on glucoregulation in physiology and diabetes.
    Vranic M; Miles P; Rastogi K; Yamatani K; Shi Z; Lickley L; Hetenyi G
    Adv Exp Med Biol; 1991; 291():161-83. PubMed ID: 1927681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathoadrenal system in neuroendocrine control of glucose: mechanisms involved in the liver, pancreas, and adrenal gland under hemorrhagic and hypoglycemic stress.
    Yamaguchi N
    Can J Physiol Pharmacol; 1992 Feb; 70(2):167-206. PubMed ID: 1521177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.